E-LIB Suche - Ergebnisse für: Dumas, Emily

1

Effect of Hepatic Impairment on Trilaciclib Pharmacokinetic:

Li, Chao ; Preston, Richard A. ; Dumas, Emily..
The Journal of Clinical Pharmacology. , 2024

Link: https://doi.org/10.1002/..

2

Premenstrual dysphoric disorder and sexual function: a narr..:

Susser, Leah C ; Parish, Sharon ; Dumas, Emily.
Sexual Medicine Reviews. 11 (2023) 3 - p. 202-211 , 2023

Link: https://doi.org/10.1093/..

3

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir an..:

Grebely, Jason ; Puoti, Massimo ; Wedemeyer, Heiner...
Open Forum Infectious Diseases. 5 (2018) 11 - p. , 2018

Link: https://doi.org/10.1093/..

4

Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A:

DeGoey, David A. ; Randolph, John T. ; Liu, Dachun...
Journal of Medicinal Chemistry. 57 (2014) 5 - p. 2047-2057 , 2014

Link: https://doi.org/10.1021/..

5

141 Baseline Characteristics of Subjects in Impact-Shpt: A ..:

Ketteler, Markus ; Martin, Kevin ; Cozzolino, Mario...
American Journal of Kidney Diseases. 57 (2011) 4 - p. B52 , 2011

Link: https://doi.org/10.1053/..

6

Safety and efficacy of glecaprevir/pibrentasvir in patients..:

Grebely, Jason ; Dore, Gregory J. ; Alami, Negar N....
International Journal of Drug Policy. 66 (2019) - p. 73-79 , 2019

Link: https://doi.org/10.1016/..

7

Dynamic changes in innate immune responses during direct‐ac..:

Holmes, Jacinta A. ; Carlton‐Smith, Charles ; Kim, Arthur Y....
Journal of Viral Hepatitis. 26 (2019) 3 - p. 362-372 , 2019

Link: https://doi.org/10.1111/..

8

Synthesis and Biological Characterization of Aryl Uracil In..:

Randolph, John T. ; Krueger, A. Chris ; Donner, Pamela L....
Journal of Medicinal Chemistry. 61 (2018) 3 - p. 1153-1163 , 2018

Link: https://doi.org/10.1021/..

9

Reduced ITPase activity and favorable IL28B genetic variant..:

Vasanthakumar, Aparna ; Davis, Justin W. ; Abunimeh, Manal...
PLOS ONE. 13 (2018) 5 - p. e0198296 , 2018

Link: https://doi.org/10.1371/..

10

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Trans..:

Reau, Nancy ; Kwo, Paul Y. ; Rhee, Susan...
Hepatology. 68 (2018) 4 - p. 1298-1307 , 2018

Link: https://doi.org/10.1002/..

11

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasv..:

Talal, Andrew H ; Dumas, Emily O ; Bauer, Barbara...
The Journal of Infectious Diseases. 217 (2017) 3 - p. 474-482 , 2017

Link: https://doi.org/10.1093/..

12

Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3..:

Polepally, Akshanth R. ; King, Jennifer R. ; Ding, Bifeng...
Clinical Pharmacokinetics. 55 (2016) 8 - p. 1003-1014 , 2016

Link: https://doi.org/10.1007/..

13

Tu1024 Plasma Interferon-γ-Inducible Protein 10 (Ip-10) and..:

Jacobson, Ira M. ; Dore, Gregory J. ; Wyles, David...
Gastroenterology. 148 (2015) 4 - p. S-1087-S-1088 , 2015

Link: https://doi.org/10.1016/..

14

1013 High SVR Rates Despite Multiple Negative Predictors in..:

Reau, Nancy ; Fried, Michael W. ; Wedemeyer, Heiner...
Gastroenterology. 148 (2015) 4 - p. S-1002 , 2015

Link: https://doi.org/10.1016/..

15

A food effect study and dose proportionality study to asses..:

Teuscher, Nathan S. ; Kelley, Richard J. ; Dumas, Emily O....
Clinical Pharmacology in Drug Development. 3 (2013) 4 - p. 314-320 , 2013

Link: https://doi.org/10.1002/..